Netherlands
Factsheet| EV/EBITDA Last | EV/EBITDA(e) 2025 | EV/EBITDA NTM | |
|---|---|---|---|
| Pharming Group NV | Free trial | Free trial | Free trial |
| International Peers | Free trial | Free trial | Free trial |
| Biotechnology | -0.75 | 0.54 | 0.71 |
| AEX 25 | 16.48 | 10.83 | 10.71 |
| Netherlands | 6.51 | 8.03 | 7.83 |
Pharming Group NV |
| Sector: Biotechnology | Ticker: PHARM | ISIN: NL0010391025 |
|
The Growth Score is a relevant measure for the assessment of a stock attractiveness. Pharming Group NV shows a Growth Score of 5.00.
The Growth Score for Pharming Group NV is higher than its peer group's. This means that Pharming Group NV has a higher growth than its peer group.
Aggregated Growth Score
In GPRV, the aggregated Growth Score is the average of the growth indicators' scores.
Net Sales Growth Historical
This is a weighted average of the Historical Growth of Net Sales. This indicator focuses on the ability of the company to grow its Net Sales year over year, historically. Up to five years of Historical Net Sales Growth are taken into account.
Calculation: (using up to 5 years of historical data when available)
[Net Sales Growth year N*5 + Net Sales Growth year (N-1)*4 + Net Sales Growth year (N-2)*3 + Net Sales Growth year (N-3)*2 + Net Sales Growth (N-4)] / 15
Net Income Growth Historical
This is a weighted average of the Historical Growth of Net Income. This indicator focuses on the ability of the company to grow its Net Income, year over year, historically. Up to five years of historical Net Income Growth are taken into account.
Calculation: (using up to 5 years of historical data when available)
[ Net Profit Growth year N*5 + Net Profit Growth year (N-1)*4 + Net Profit Growth year (N-2)*3 + Net Profit Growth year(N-3)*2 + Net Profit Growth (N-4)]/15
Net Sales Growth Estimate
This is a Forecast CAGR (Compound Annual Growth Rate) of Net Sales Estimates.
Calculation: (using up to 3 years of forecast data when available)
(Net Sales year (N+2) – Net Sales year N)(1/2)
EPS Growth Estimate
This is a Forecast CAGR (Compound Annual Growth Rate) of EPS estimates.
Calculation: (using up to 3 years of forecast data when available)
(EPS year (N+2) – EPS year N)(1/2)